pre-miRNA Information
pre-miRNA hsa-mir-1246   
Genomic Coordinates chr2: 176600980 - 176601052
Synonyms MIRN1246, hsa-mir-1246, MIR1246
Description Homo sapiens miR-1246 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-1246
Sequence 11| AAUGGAUUUUUGGAGCAGG |29
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1489969781 2 dbSNP
rs757265617 6 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol USP48   
Synonyms RAP1GA1, USP31
Description ubiquitin specific peptidase 48
Transcript NM_032236   
Other Transcripts NM_001032730   
Expression
Putative miRNA Targets on USP48
3'UTR of USP48
(miRNA target sites are highlighted)
>USP48|NM_032236|3'UTR
   1 TCTTTGAATACTTGCTGACTGCTAAGAAATGACCAGAGGGGAAGAGGAGTTTGACATGTTAGGGCATTAAAGCAAAGGTG
  81 GATTTAAGAATTAAACCATTACATGCCCCTTCCAAAAGGCAGAAATCCATTCAAACGTGACTGTCCCAAATGCCTTATGT
 161 CAAATAAAGCAGATTGCACTGATGGACATCAGACTTGAAGGAAATGTTTCCAATTTTATATTTAAGGGGGGTGGTGGGTG
 241 GGAGGGGGCAAGTAAAGACGGAACAAGTTTAGTAGCAGTAATAGTAAATCATGTTTACATATGAGATTTATAGTCGTGGG
 321 AGGGGAATAAAGTTCTGTTATATTTCCTTGCTCGAGTTTCATACCAGATGCGTTGGTCCATAAAGGATTGTATCAAGTAG
 401 ATGGGACAACATTCTGCTCTGAACGAAAAGTAATTTTAGAGACATAACCTGCTTACCAATGCCTGTCTTTGATTCATATT
 481 CTACTTTCAATAAAGCATGAAAGTGAAGAACTTGTCCTAAGTGTGGAAAAGTGTCTTCAGATTTAGACTCTTCTCCATGT
 561 CAGCTGCAGCGCCACCCGCCTTACACCTGCCCGGCCGTCTGTCTCTTGGTATTGGGTAAAGGAGGGGGCACCTGCATGTC
 641 TCCTGCAATGAGCAAGGAATTATGTCTCATGTTTTGACTTCAGAGGCTTTTTGCTTTGGTGCATTTCAGAAAGGATGGAG
 721 AACATTTATTATGTGTGAAAGCATCCTCTTCCGGTTTTGCTGTTATTCAAAAGTGGGAAATGTACCTGGCACGTTTGAAA
 801 ATAAAAAATCTGACTACCTATCAGAAGAGTAAATCAGAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ggacgagGUUUUUAGGUAa 5'
                 ||:|||||||| 
Target 5' caaaaggCAGAAATCCATt 3'
113 - 131 156.00 -13.00
2
miRNA  3' ggaCGAGGUUU----UUAGGUAa 5'
             | |::||:    || |||| 
Target 5' gtgGATTTAAGAATTAAACCATt 3'
78 - 100 114.00 -6.60
3
miRNA  3' ggaCGAGGUUUUUAGGUAa 5'
             | | |:  ::||||| 
Target 5' ccaGATGCGTTGGTCCATa 3'
364 - 382 112.00 -8.70
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30480536 62 COSMIC
COSN30534644 82 COSMIC
COSN31606250 88 COSMIC
COSN31538182 100 COSMIC
COSN30109323 108 COSMIC
COSN30508817 108 COSMIC
COSN30493175 124 COSMIC
COSN32053869 134 COSMIC
COSN27004423 148 COSMIC
COSN31546363 193 COSMIC
COSN25422805 225 COSMIC
COSN28744083 245 COSMIC
COSN21205028 570 COSMIC
COSN22322017 1037 COSMIC
rs78337240 399 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs368352580 10 dbSNP
rs1468613117 14 dbSNP
rs771466002 16 dbSNP
rs1257385209 17 dbSNP
rs1210271221 19 dbSNP
rs745580593 22 dbSNP
rs1298512658 24 dbSNP
rs778674564 30 dbSNP
rs1028712099 33 dbSNP
rs1365769468 34 dbSNP
rs1296682286 43 dbSNP
rs1432616022 48 dbSNP
rs746901254 57 dbSNP
rs949125143 72 dbSNP
rs998213927 77 dbSNP
rs1355837648 80 dbSNP
rs186995427 81 dbSNP
rs773166264 84 dbSNP
rs1328360891 113 dbSNP
rs565484355 121 dbSNP
rs140288196 122 dbSNP
rs768662799 127 dbSNP
rs1441547875 128 dbSNP
rs774137482 129 dbSNP
rs1018823123 134 dbSNP
rs1004662822 137 dbSNP
rs886299680 142 dbSNP
rs1454458159 143 dbSNP
rs1048791991 149 dbSNP
rs937474730 158 dbSNP
rs930362163 163 dbSNP
rs1228979763 171 dbSNP
rs1352061888 173 dbSNP
rs1197509355 177 dbSNP
rs1482210930 184 dbSNP
rs113660412 199 dbSNP
rs1254335004 202 dbSNP
rs1233580057 210 dbSNP
rs1348663592 213 dbSNP
rs1282275776 225 dbSNP
rs1238206688 226 dbSNP
rs1376690264 227 dbSNP
rs182665037 229 dbSNP
rs1393652788 231 dbSNP
rs1359897744 232 dbSNP
rs1055159949 233 dbSNP
rs1336440369 235 dbSNP
rs1434871164 236 dbSNP
rs939007486 238 dbSNP
rs1455666598 239 dbSNP
rs1388064174 243 dbSNP
rs1059218 245 dbSNP
rs1473897210 259 dbSNP
rs978378715 260 dbSNP
rs1421997942 270 dbSNP
rs1181582080 277 dbSNP
rs1255453462 283 dbSNP
rs1211496785 290 dbSNP
rs945509704 291 dbSNP
rs1486062685 299 dbSNP
rs780247231 302 dbSNP
rs1214748916 305 dbSNP
rs1350173788 310 dbSNP
rs1280520758 315 dbSNP
rs1241698219 316 dbSNP
rs1339073994 318 dbSNP
rs192015805 325 dbSNP
rs368722392 328 dbSNP
rs1356842373 332 dbSNP
rs187285308 336 dbSNP
rs954244275 337 dbSNP
rs1266982763 341 dbSNP
rs183514931 347 dbSNP
rs1159922915 353 dbSNP
rs976685011 354 dbSNP
rs965381235 359 dbSNP
rs1331208538 361 dbSNP
rs78452980 362 dbSNP
rs533887228 367 dbSNP
rs556233716 371 dbSNP
rs867217351 372 dbSNP
rs1191527058 375 dbSNP
rs1027879338 377 dbSNP
rs1285301514 384 dbSNP
rs1207088631 390 dbSNP
rs1286157005 391 dbSNP
rs1047464755 396 dbSNP
rs78337240 399 dbSNP
rs1234478247 402 dbSNP
rs367780877 407 dbSNP
rs896261425 410 dbSNP
rs1321369041 414 dbSNP
rs1429484676 416 dbSNP
rs1326499024 423 dbSNP
rs752047653 424 dbSNP
rs745732968 425 dbSNP
rs927471719 440 dbSNP
rs1054916625 444 dbSNP
rs1406268943 451 dbSNP
rs1003208066 459 dbSNP
rs1475149464 467 dbSNP
rs577025920 479 dbSNP
rs1195633673 487 dbSNP
rs759036183 497 dbSNP
rs1214640381 502 dbSNP
rs1185016388 516 dbSNP
rs947634262 517 dbSNP
rs913475409 532 dbSNP
rs1339541629 540 dbSNP
rs558806193 546 dbSNP
rs1042649826 553 dbSNP
rs1230645430 560 dbSNP
rs988810606 565 dbSNP
rs1326155267 566 dbSNP
rs933303021 567 dbSNP
rs75527287 570 dbSNP
rs770708911 571 dbSNP
rs1486582004 576 dbSNP
rs1054321974 577 dbSNP
rs1169660673 578 dbSNP
rs571211433 585 dbSNP
rs1016521923 589 dbSNP
rs1394765960 592 dbSNP
rs373645660 593 dbSNP
rs548295895 594 dbSNP
rs976842288 596 dbSNP
rs1204466866 597 dbSNP
rs1291846593 605 dbSNP
rs1438857952 609 dbSNP
rs867454791 610 dbSNP
rs965338232 614 dbSNP
rs535914380 615 dbSNP
rs1198169764 622 dbSNP
rs908524082 623 dbSNP
rs982766855 628 dbSNP
rs1298616439 629 dbSNP
rs896167945 635 dbSNP
rs1278699251 636 dbSNP
rs1442846866 638 dbSNP
rs368431407 642 dbSNP
rs867006356 643 dbSNP
rs1027581727 648 dbSNP
rs1293433059 660 dbSNP
rs1374891389 662 dbSNP
rs903567589 664 dbSNP
rs1455708081 666 dbSNP
rs1378887561 668 dbSNP
rs1176916002 669 dbSNP
rs995071276 670 dbSNP
rs959274538 679 dbSNP
rs1235168323 691 dbSNP
rs1437851779 693 dbSNP
rs1485087301 697 dbSNP
rs1280358585 714 dbSNP
rs1033410120 715 dbSNP
rs1350970700 718 dbSNP
rs1283314033 728 dbSNP
rs868035727 731 dbSNP
rs867955108 732 dbSNP
rs1414064344 741 dbSNP
rs147153186 743 dbSNP
rs1313515308 752 dbSNP
rs550267567 753 dbSNP
rs1042051448 754 dbSNP
rs1158637703 758 dbSNP
rs1401693408 761 dbSNP
rs933542975 766 dbSNP
rs1009237757 767 dbSNP
rs1190546656 770 dbSNP
rs894013542 783 dbSNP
rs532857237 784 dbSNP
rs1189379681 785 dbSNP
rs1270982415 789 dbSNP
rs1241223430 792 dbSNP
rs565211315 793 dbSNP
rs1202680880 800 dbSNP
rs766051149 814 dbSNP
rs1341234458 820 dbSNP
rs1287405415 821 dbSNP
rs1232635067 822 dbSNP
rs1335321756 824 dbSNP
rs932808250 827 dbSNP
rs1293996403 830 dbSNP
rs760474034 839 dbSNP
rs546819189 842 dbSNP
rs1416762302 856 dbSNP
rs1359920236 857 dbSNP
rs528648699 858 dbSNP
rs1041213260 860 dbSNP
rs943484579 864 dbSNP
rs1461394405 867 dbSNP
rs1167736651 870 dbSNP
rs1275557660 871 dbSNP
rs1260402793 879 dbSNP
rs944104070 884 dbSNP
rs909297506 890 dbSNP
rs561088332 894 dbSNP
rs908638047 914 dbSNP
rs1310485604 917 dbSNP
rs113663369 918 dbSNP
rs1220299450 925 dbSNP
rs1468738204 937 dbSNP
rs950567251 941 dbSNP
rs1216699965 948 dbSNP
rs868488590 951 dbSNP
rs1026123457 958 dbSNP
rs931366106 959 dbSNP
rs920505911 963 dbSNP
rs1321568003 965 dbSNP
rs973368181 971 dbSNP
rs371062651 974 dbSNP
rs959454543 975 dbSNP
rs1328574122 978 dbSNP
rs10917034 981 dbSNP
rs368701503 982 dbSNP
rs1308235785 994 dbSNP
rs748123518 996 dbSNP
rs1012185265 1000 dbSNP
rs1192613059 1000 dbSNP
rs970425460 1002 dbSNP
rs1254596521 1007 dbSNP
rs1194036723 1011 dbSNP
rs563714151 1014 dbSNP
rs1375416216 1022 dbSNP
rs1250846766 1042 dbSNP
rs1053190343 1043 dbSNP
rs891974750 1043 dbSNP
rs192131755 1048 dbSNP
rs1433272658 1055 dbSNP
rs1009636365 1058 dbSNP
rs893510356 1060 dbSNP
rs933585034 1063 dbSNP
rs1306027914 1065 dbSNP
rs1390170336 1070 dbSNP
rs577092432 1078 dbSNP
rs1032986433 1079 dbSNP
rs1288155631 1094 dbSNP
rs1463129192 1096 dbSNP
rs1373063569 1098 dbSNP
rs1179951451 1103 dbSNP
rs1434907998 1104 dbSNP
rs1396668799 1105 dbSNP
rs1482592274 1115 dbSNP
rs200312469 1116 dbSNP
rs397727492 1117 dbSNP
rs558873622 1117 dbSNP
rs1178851348 1119 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293
Disease 84196.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1 "PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ggacgagguUUUUAGGUAa 5'
                   ||||||||| 
Target 5' ---------AAAAUCCAUu 3'
1 - 10
Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
CLIP-seq Support 1 for dataset GSM4903825
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / PID14_NS
Location of target site NM_032236 | 3UTR | ACAUGCCCCUUCCAAAAGGCAGAAAUCCAUUCAAAC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161237
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM714642
Method / RBP HITS-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000219689.7 | 3UTR | AAAAUCCAUUACACAGUCACUUUACG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM714644
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000219689.7 | 3UTR | AAAAUCCAUUACACAGUCACUUUACG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE28544 Breast cancer -0.249 1.2e-1 -0.063 3.8e-1 24 Click to see details
GSE42095 Differentiated embryonic stem cells -0.254 1.2e-1 -0.135 2.7e-1 23 Click to see details
GSE28260 Renal cortex and medulla 0.293 1.7e-1 0.302 1.6e-1 13 Click to see details
GSE38974 Chronic obstructive pulmonary disease 0.184 1.9e-1 0.187 1.9e-1 25 Click to see details
GSE38226 Liver fibrosis -0.18 2.2e-1 -0.418 3.0e-2 21 Click to see details
GSE26953 Aortic valvular endothelial cells -0.069 3.7e-1 -0.170 2.1e-1 24 Click to see details
GSE32688 Pancreatic cancer -0.045 4.0e-1 -0.075 3.4e-1 32 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
HNSC -0.48 0.17 -0.429 0.2 6 Click to see details
HNSC -0.48 0.17 -0.429 0.2 6 Click to see details
HNSC -0.48 0.17 -0.429 0.2 6 Click to see details
52 hsa-miR-1246 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT053774 DYRK1A dual specificity tyrosine phosphorylation regulated kinase 1A 4 1
MIRT196431 TAOK1 TAO kinase 1 2 6
MIRT444394 ZNF480 zinc finger protein 480 2 2
MIRT447596 MSH3 mutS homolog 3 2 2
MIRT454049 TMBIM4 transmembrane BAX inhibitor motif containing 4 2 2
MIRT458257 ZNF85 zinc finger protein 85 2 2
MIRT461493 KIAA1009 centrosomal protein 162 1 1
MIRT474057 LMNB2 lamin B2 2 2
MIRT479231 CKS2 CDC28 protein kinase regulatory subunit 2 2 6
MIRT485663 CHD7 chromodomain helicase DNA binding protein 7 2 2
MIRT485735 CALM2 calmodulin 2 2 2
MIRT498809 SRRT serrate, RNA effector molecule 2 8
MIRT501190 SKIL SKI like proto-oncogene 2 2
MIRT502619 DGS2 DiGeorge syndrome/velocardiofacial syndrome complex 2 2 6
MIRT502665 CTC1 CST telomere replication complex component 1 2 13
MIRT512313 ADCY9 adenylate cyclase 9 2 6
MIRT513756 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 2
MIRT514651 CRADD CASP2 and RIPK1 domain containing adaptor with death domain 2 2
MIRT514865 SHOX2 short stature homeobox 2 2 2
MIRT527109 ARHGAP15 Rho GTPase activating protein 15 2 2
MIRT527145 GPATCH11 G-patch domain containing 11 2 2
MIRT528507 HTR7 5-hydroxytryptamine receptor 7 2 4
MIRT532109 RRP8 ribosomal RNA processing 8 2 2
MIRT534601 RORA RAR related orphan receptor A 2 2
MIRT538906 BRI3BP BRI3 binding protein 2 4
MIRT544541 GDE1 glycerophosphodiester phosphodiesterase 1 2 2
MIRT547430 MED4 mediator complex subunit 4 2 2
MIRT553029 USP48 ubiquitin specific peptidase 48 2 2
MIRT555136 PTPRD protein tyrosine phosphatase, receptor type D 2 2
MIRT562091 KIAA0895 KIAA0895 2 2
MIRT562584 CBX3 chromobox 3 2 4
MIRT563747 ZNF763 zinc finger protein 763 2 2
MIRT573310 AKR7A2 aldo-keto reductase family 7 member A2 2 2
MIRT687232 PLAGL2 PLAG1 like zinc finger 2 2 2
MIRT704465 CREBRF CREB3 regulatory factor 2 2
MIRT718817 PYGO1 pygopus family PHD finger 1 2 2
MIRT731194 NFIB nuclear factor I B 2 1
MIRT732503 SPRED2 sprouty related EVH1 domain containing 2 3 0
MIRT733489 MIF macrophage migration inhibitory factor 2 0
MIRT734071 SRSF1 serine and arginine rich splicing factor 1 2 0
MIRT734733 AR androgen receptor 3 0
MIRT734755 GLS2 glutaminase 2 2 0
MIRT735248 CFTR cystic fibrosis transmembrane conductance regulator 8 1
MIRT736017 ELAVL1 ELAV like RNA binding protein 1 2 0
MIRT736329 DNAH3 dynein axonemal heavy chain 3 2 0
MIRT737381 CCNG2 cyclin G2 2 0
MIRT755524 FOXA2 forkhead box A2 3 1
MIRT755713 DIXDC1 DIX domain containing 1 2 1
MIRT755714 WNT9A Wnt family member 9A 2 1
MIRT755715 RAC2 Rac family small GTPase 2 2 1
MIRT755716 FRAT2 FRAT2, WNT signaling pathway regulator 2 1
MIRT756132 ACE2 angiotensin I converting enzyme 2 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-1 Anthocyanin NULL 145858 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Caffeic acid NULL 689043 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Catechin approved 9064 Microarray apoE−/− mice 22253797 2012 up-regulated
miR-1 Curcumin NULL 969516 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Ferulic acid NULL 445858 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Hesperidin NULL 10621 Microarray apoE−/− mice 22253797 2012 up-regulated
miR-1 Quercetin NULL 5280343 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Galactose NULL 6036 Quantitative real-time PCR lens 22736950 2012 up-regulated
miR-1 Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse brain 19270793 2009 down-regulated
miR-1 Trichostatin A (TSA) NULL 444732 Quantitative real-time PCR myocardial differentiation of mouse ES cells 19521018 2009 down-regulated
miR-1 Sulfonyl-hydrazone-1 (SHZ) NULL NULL Quantitative real-time PCR Murine broblast-derived Induced pluripotent stem cells 21445862 2011 up-regulated
miR-1 Cocaine NULL 446220 Next-generation sequencing ventral striatum 21708909 2011 up-regulated
miR-1 Atorvastatin approved 60823 Quantitative real-time PCR Cardiomyocyte 23860036 2013 down-regualted
miR-1 Glucose NULL 5793 Quantitative real-time PCR endothelial cells 24394957 2014 down-regulated
miR-1 Docosahexaenoic acid NULL 445580 Quantitative real-time PCR Caco-2 cells 24623846 2014 up-regulated
miR-1 Palmitic acid approved 985 Quantitative real-time PCR Caco-2 cells 24623846 2014 up-regulated
miR-1 17beta-estradiol (E2) approved 5757 Microarray MCF-7AKT breast cancer cells 19528081 2009 down-regulated
miR-1 Essential amino acids (EAA) NULL NULL Quantitative real-time PCR skeletal muscle of young adults 19828686 2009 up-regulated
miR-1 Hydrogen peroxide (H2O2) NULL 784 Quantitative real-time PCR Human umbilical vein endothelial cells 21527937 2011 down-regulated
miR-1 Trichostatin A (TSA) NULL 444732 Microarray apoptosis-resistant breast cancer cells 21971930 2011 up-regulated
miR-1 Arsenic trioxide approved 14888 Quantitative real-time PCR acute promyelocytic leukemia 22072212 2012 up-regulated
miR-1 5-Fluorouracil approved 3385 Microarray CNE cells 22614822 2012 up-regulated
miR-1 Bicalutamide approved 2375 Microarray prostate 22674191 2012 up-regulated
miR-1 Arsenic trioxide approved 14888 Quantitative real-time PCR cardia 22889704 2012 up-regulated
miR-1 Perfluorooctane sulfonate NULL 74483 Microarray zebrafish embryos 20878907 2011 up-regulated
miR-1 Quinidine approved 441074 Quantitative real-time PCR myocardial infarction (MI) rats 19775284 2009 up-regulated
miR-1 Tanshinone IIA NULL 164676 Quantitative real-time PCR myocardial infarction (MI) rats 19775284 2009 down-regulated
miR-1 Tanshinone IIA NULL 164676 Quantitative real-time PCR post-infarction rat cardiomyocytes 21220930 2011 down-regulated
miR-1 Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 down-regulated
miR-1 Dexamethasone approved 5743 Microarray adrenals and granulosa cells 24205079 2014 up-regulated
miR-1 Thiourea (TU) NULL 737139 Quantitative real-time PCR skeletal muscle and heart 22142802 2012 up-regulated
miR-1 Thiourea (TU) NULL 737139 Quantitative real-time PCR skeletal muscle and heart 22142802 2012 down-regulated
miR-1 Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 up-regulated
miR-1246 Hydroxycamptothecin (HCPT) NULL 97226 Microarray human Tenon's fibroblasts (HTFs) 24681041 2014 up-regulated
miR-1246 Ascorbate approved 54670067 Microarray Metastatic melanoma cell lines 25202679 2014 up-regualted
miR-1246 5-Fluorouracil approved 3385 Microarray MCF-7 breast cancer cells 21506117 2011 up-regulated
miR-1246 Marine fungal metabolite 1386A NULL NULL Microarray MCF-7 breast cancer cells. 22159329 2012 down-regulated
miR-1246 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 up-regulated
miR-1246 Trastuzumab approved NULL Microarray SKBR3 cells. 22384020 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant High Bladder Cancer cell line (RT4, J82,TCCSUP, UM-UC-3,RT112,CUBIII)
hsa-miR-1246 Oxaliplatin 6857599 NSC266046 approved resistant High Colorectal Cancer cell line (HT-29)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Lung Adenocarcinoma cell line (A549)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved resistant High Gastric Cancer cell line (SGC7901)
hsa-miR-1246 Vincristine 5978 approved resistant High Gastric Cancer cell line (SGC7901)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Pancreatic Cancer cell line (MIA-PaCa-2, PANC-1)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (MIA-PaCa-2, PANC-1)
hsa-miR-1246 Platinum-based doublet chemotherapy sensitive High Lung Adenocarcinoma tissue
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Ductal Adenocarcinoma cell line (BxPC-3)
hsa-miR-1246 Bortezomib 387447 NSC681239 approved resistant High Multiple Myeloma cell line
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1246 Mitoxantrone 4212 NSC279836 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer cell line (MDA-MB-231, MCF-7)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant Low Hepatocellular Carcinoma cell line (Hep3B, Huh-7)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Hepatocellular Carcinoma cell line (Hep3B, Huh-7)
hsa-miR-1246 Sorafenib 216239 NSC747971 approved resistant Low Hepatocellular Carcinoma cell line (Hep3B, Huh-7)
hsa-miR-1246 Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant High Gallbladder Cancer cell line (GBC-SD, NOZ)
hsa-miR-1246 Plx-4720 24180719 NSC757438 resistant Low Melanoma cell line (A375P, SK-MEL-2)
hsa-miR-1246 Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Breast Cancer cell line (BCap37, Bads-200, Bats-72)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant Low Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Epirubicin 41867 NSC256942 approved resistant Low Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, GNM, OC3, Fadu)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (M14) (1uM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (M14) (2uM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (M14) (1uM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (M14) (200nM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (M14) (50nM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved sensitive High Melanoma cell line (M14) (50nM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (WM266) (200nM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved sensitive High Melanoma cell line (WM266) (200nM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (M14) (2uM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved sensitive High Melanoma cell line (M14) (200nM)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant Low Ovarian Cancer cell line (HeyA8, SKOV3, A2780, THP-1)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant Low Tongue Squamous Cell Carcinoma cell line (CAL-27)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Colorectal Cancer cell line (HCT-116, HCT-8)
hsa-miR-1246 Oxaliplatin 6857599 NSC266046 approved resistant Low Colorectal Cancer cell line (HCT-116, HCT-8)
hsa-miR-1246 Erlotinib 176870 NSC718781 approved sensitive High Head And Neck Squamous Cell Carcinoma cell line (HN6)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Breast Cancer cell line (BCap37)
hsa-miR-1246 Trastuzumab resistant Low HER2-Positive Breast Cancer tissue
hsa-miR-1246 Temozolomide 5394 NSC362856 approved sensitive Low Glioblastoma cell line (U87)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved resistant Low Leukemia cell line (K562/ADM and HL-60/RS)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Melanoma cell line (A375)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved sensitive Low Breast Cancer tissue and cell line (MCF-7, MDA-MB-231, MDA-MB-468, SKBR3)
hsa-miR-1246 Antiepileptic Drug resistant High Pediatric Epilepsy tissue
hsa-mir-1246 Vincristine 5978 approved resistant cell line (W1)
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (KYSE)
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-mir-1246 Decitabine 451668 approved sensitive tissue (esopheageal cancer)
hsa-miR-1246 Temozolomide 5394 NSC362856 approved resistant cell line (U251)
hsa-miR-1246 Gefitinib 123631 NSC715055 approved resistant cell line (PC9)
hsa-miR-1246 Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-1246 Osimertinib 71496458 NSC779217 approved sensitive cell line (HCC827)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (CAL-27) (total RNA)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-1246 Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM47)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant cell line (LM11)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant cell line (LM36)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved sensitive cell line (HS578T)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-1246 Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-1246 4-Hydroxytamoxifen+Tamoxifen sensitive cell line (LY2)
hsa-miR-1246 Ethanol+Tamoxifen sensitive cell line (LY2)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved resistant cell line (K562)
hsa-miR-1246 Platinum-based doublet chemotherapy sensitive tissue (lung adenocarcinoma)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (IGROV-1)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR3)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR4)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-1246 Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide resistant cell line (Bads-200)
hsa-miR-1246 Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine resistant cell line (Bats-72)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved sensitive cell line (OVSAHO)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (TOV-112D)

Error report submission